About DOMESCO
DOMESCO is a publicly listed company based in Long Xuyen (Vietnam) founded in 1989. Pharmaceuticals, foods, herbals, and medical devices are imported and exported. DOMESCO has raised $9 million across 1 funding round from investors including Laboratorios Recalcine. DOMESCO offers products and services including TÂM AN VIÊN, THANH PHẾ DOMESCO, AN ĐƯỜNG VIÊN, DO-ADAM FORTE, and HOẠT HUYẾT DƯỠNG NÃO. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU Y TẾ DOMESCO. Its competitors include HDPHARMA, SPMoration and Bao Chau Pharmaceutical Group.
Company details
DOMESCO was founded in 1989 and operates in the import and export sector for pharmaceutical medicines, raw materials, food products, functional foods, herbal items, medical devices, and supplies. Focus is placed on antibiotics, analgesics, respiratory treatments, minerals, vitamins, cardiovascular medicines, and APIs. Operations are based in Long Xuyen, Vietnam, with presence established in 12 countries, including Japan and Korea.
- Headquarters Long Xuyen, Vietnam
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website domesco.com
- Social LinkedIn
- Legal Name Domesco Medical Import-Export Jsc
- Annual Revenue$2070 B8.84as on Dec 31, 2025
- Net Profit$168.64 B-2.13as on Dec 31, 2025
- EBITDA$240.16 B-1.31as on Dec 31, 2025
- Total Equity Funding$9M (USD)
in 1 rounds
- Latest Funding Round$9M (USD), Series A
Dec 2011
- Investors
Products & Services of DOMESCO
DOMESCO offers a comprehensive portfolio of products and services, including TÂM AN VIÊN, THANH PHẾ DOMESCO, AN ĐƯỜNG VIÊN, DO-ADAM FORTE, and HOẠT HUYẾT DƯỠNG NÃO.
Supplement for general health support and well-being.
Medicine targeted at respiratory health issues.
Product for diabetes management and blood sugar control.
Nutritional supplement for vitality and energy boost.
Aid for brain health and blood circulation improvement.
Medicine for pain relief and fever reduction.
Turmeric-based product for anti-inflammatory benefits.
Funding Insights of DOMESCO
DOMESCO has successfully raised a total of $9M through 1 strategic funding round. The most recent funding activity was a Series A round of $9 million completed in December 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9M
- Total Rounds 1
- Last Round Series A — $9M
- First Round $9M
(Dec 2011)
- Investors Count 1
All 1 funding rounds of DOMESCO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2011 | $9M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in DOMESCO
DOMESCO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Laboratorios Recalcine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| recalcine.cl |
Investor details for DOMESCO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of DOMESCO
DOMESCO is a publicly listed company on the HOSE with ticker symbol DMC in Vietnam, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Dec 2006
- Listed onHOSE: DMC
- Listed entityDomesco Medical Import-Export JSC
- Exchange sectorHealth technology
- ISINVN000000DMC9
- Share price53,600.00 VND (-0.74% on the day) · 2026-10-14
- Market capitalisation1,875,283,195,496.00 VND
- Price to earnings8.9
- EPS (diluted, trailing year)5,993.65 VND
- Dividend yield4.63%
- Volume (last session)300
Financials of DOMESCO
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2,070.00B VND | 168.64B VND | 240.16B VND |
| 2024 | 1,900.00B VND | 172.30B VND | 243.36B VND |
| 2023 | 1,720.00B VND | 155.83B VND | 202.43B VND |
| 2022 | 1,590.00B VND | 200.08B VND | 254.18B VND |
| 2021 | 1,500.00B VND | 159.28B VND | 210.55B VND |
Detailed financial statements for DOMESCO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of DOMESCO
3 dated milestones of DOMESCO across 22 years, from founding to its latest funding, stage changes and deals.
- Founded DOMESCO is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $9.0M.
Competitors of DOMESCO
DOMESCO has 3 listed competitors in our database. They include HDPHARMA, SPMoration and Bao Chau Pharmaceutical Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hdpharma.vn | 1961 | Hai Duong, Vietnam | Manufactures and distributes drugs and health supplements for consumers. | |||
| spm.com.vn | 1988 | Ho Chi Minh, Vietnam | Manufactures and distributes pharmaceuticals, vitamins, and health supplements in Vietnam. | |||
| duocbaochau.com.vn | 2014 | Dong Da, Vietnam | Distributor of pharmaceutical products |
Detailed competitors of DOMESCO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DOMESCO
The website of DOMESCO (domesco.com) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 49.5% vs previous month
Websites whose visitors overlap most with DOMESCO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| imexpharm.com | 100% | 20.8K | #1,053,161 | View details | |
| traphaco.com.vn | 99% | 19.5K | #1,451,220 | View details | |
santhuoc.net | santhuoc.net | 98% | #979,132 | – | |
| pymepharco.com | 91% | 1.4K | #10,525,481 | View details | |
parapharmacy.vn | parapharmacy.vn | 90% | #1,164,746 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for DOMESCO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Domesco
Complete news archive for DOMESCO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DOMESCO
DOMESCO was founded in 1989 and raised its 1st funding round 22 years after it was founded.
DOMESCO is headquartered in Long Xuyen, Vietnam. It is registered at Long Xuyen, An Giang, Vietnam.
DOMESCO is a funded company, having raised a total of $9M across 1 funding round to date. The company's 1st funding round was a Series A of $9M, raised on Dec 2011.
DOMESCO was founded in 1989 and operates in the import and export sector for pharmaceutical medicines, raw materials, food products, functional foods, herbal items, medical devices, and supplies. Focus is placed on antibiotics, analgesics, respiratory treatments, minerals, vitamins, cardiovascular medicines, and APIs. Operations are based in Long Xuyen, Vietnam, with presence established in 12 countries, including Japan and Korea.
DOMESCO's top competitors include Bao Chau Pharmaceutical Group, HDPHARMA and SPMoration.
DOMESCO offers TÂM AN VIÊN, THANH PHẾ DOMESCO, AN ĐƯỜNG VIÊN, DO-ADAM FORTE, and 3 more products and services.
Yes, DOMESCO is publicly traded on HOSE under the ticker symbol DMC.
DOMESCO has 1 investor. Key investors include Laboratorios Recalcine.
DOMESCO operates through Công Ty Cổ Phần Xuất Nhập Khẩu Y Tế Domesco.